Literature DB >> 27037327

Gut microbiota and protection from pneumococcal pneumonia.

Robert P Dickson1, Michael J Cox2.   

Abstract

Entities:  

Keywords:  BACTERIAL INFECTION; INFECTIOUS DISEASE; INTESTINAL MICROBIOLOGY

Mesh：

Year:  2016        PMID： 27037327      PMCID： PMC5083249          DOI： 10.1136/gutjnl-2016-311823

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

1.  The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.

Authors:  Geraint B Rogers; Kenneth D Bruce; Megan L Martin; Lucy D Burr; David J Serisier
Journal:  Lancet Respir Med       Date:  2014-10-14       Impact factor: 30.700

2.  Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation.

Authors:  Leopoldo N Segal; Alexander V Alekseyenko; Jose C Clemente; Rohan Kulkarni; Benjamin Wu; Zhan Gao; Hao Chen; Kenneth I Berger; Roberta M Goldring; William N Rom; Martin J Blaser; Michael D Weiden
Journal:  Microbiome       Date:  2013-07-01       Impact factor: 14.650

3.  The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia.

Authors:  Tim J Schuijt; Jacqueline M Lankelma; Brendon P Scicluna; Felipe de Sousa e Melo; Joris J T H Roelofs; J Daan de Boer; Arjan J Hoogendijk; Regina de Beer; Alex de Vos; Clara Belzer; Willem M de Vos; Tom van der Poll; W Joost Wiersinga
Journal:  Gut       Date:  2015-10-28       Impact factor: 23.059

4.  Lung microbiota promotes tolerance to allergens in neonates via PD-L1.

Authors:  Eva S Gollwitzer; Sejal Saglani; Aurélien Trompette; Koshika Yadava; Rebekah Sherburn; Kathy D McCoy; Laurent P Nicod; Clare M Lloyd; Benjamin J Marsland
Journal:  Nat Med       Date:  2014-05-11       Impact factor: 53.440

5.  The impact of azithromycin therapy on the airway microbiota in asthma.

Authors:  Mariel Slater; Damian W Rivett; Lisa Williams; Matthew Martin; Tim Harrison; Ian Sayers; Kenneth D Bruce; Dominick Shaw
Journal:  Thorax       Date:  2013-11-28       Impact factor: 9.139
  5 in total
  11 in total

1.  The Lung Microbiota of Healthy Mice Are Highly Variable, Cluster by Environment, and Reflect Variation in Baseline Lung Innate Immunity.

Authors:  Robert P Dickson; John R Erb-Downward; Nicole R Falkowski; Ellen M Hunter; Shanna L Ashley; Gary B Huffnagle
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

2.  Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions.

Authors:  Zhengzheng Yan; Boxuan Chen; Yuqiong Yang; Xinzhu Yi; Mingyuan Wei; Gertrude Ecklu-Mensah; Mary M Buschmann; Haiyue Liu; Jingyuan Gao; Weijie Liang; Xiaomin Liu; Junhao Yang; Wei Ma; Zhenyu Liang; Fengyan Wang; Dandan Chen; Lingwei Wang; Weijuan Shi; Martin R Stampfli; Pan Li; Shenhai Gong; Xia Chen; Wensheng Shu; Emad M El-Omar; Jack A Gilbert; Martin J Blaser; Hongwei Zhou; Rongchang Chen; Zhang Wang
Journal:  Nat Microbiol       Date:  2022-08-22       Impact factor: 30.964

Review 3.  Emerging pathogenic links between microbiota and the gut-lung axis.

Authors:  Kurtis F Budden; Shaan L Gellatly; David L A Wood; Matthew A Cooper; Mark Morrison; Philip Hugenholtz; Philip M Hansbro
Journal:  Nat Rev Microbiol       Date:  2016-10-03       Impact factor: 60.633

4.  The Metabolic Sensor GPR43 Receptor Plays a Role in the Control of Klebsiella pneumoniae Infection in the Lung.

Authors:  Izabela Galvão; Luciana P Tavares; Renan O Corrêa; José Luís Fachi; Vitor Melo Rocha; Marcela Rungue; Cristiana C Garcia; Geovanni Cassali; Caroline M Ferreira; Flaviano S Martins; Sergio C Oliveira; Charles R Mackay; Mauro M Teixeira; Marco Aurélio R Vinolo; Angélica T Vieira
Journal:  Front Immunol       Date:  2018-02-20       Impact factor: 7.561

5.  The microbiota protects against respiratory infection via GM-CSF signaling.

Authors:  Rebecca L Brown; Richard P Sequeira; Thomas B Clarke
Journal:  Nat Commun       Date:  2017-11-15       Impact factor: 14.919

6.  Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial.

Authors:  Rea Bingula; Edith Filaire; Ioana Molnar; Eve Delmas; Jean-Yves Berthon; Marie-Paule Vasson; Annick Bernalier-Donadille; Marc Filaire
Journal:  Respir Res       Date:  2020-05-25

7.  Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis.

Authors:  Hui Lu; Na L Gao; Fan Tong; Jiaojiao Wang; Huanhuan Li; Ruiguang Zhang; Hong Ma; Nong Yang; Yongchang Zhang; Ye Wang; Zhiwen Liang; Hao Zeng; Wei-Hua Chen; Xiaorong Dong
Journal:  Microbiol Spectr       Date:  2021-11-17

8.  Informatic analysis of the pulmonary microecology in non-cystic fibrosis bronchiectasis at three different stages.

Authors:  Yuchao Wang; Ying Chen; Chao Wu; Xiaohong Yang
Journal:  Open Life Sci       Date:  2022-02-28       Impact factor: 1.311

9.  Alterations in the Gut Microbiome and Cecal Metabolome During Klebsiella pneumoniae-Induced Pneumosepsis.

Authors:  Ting Wu; Fangming Xu; Cong Su; Hongru Li; Na Lv; Yanyan Liu; Yufeng Gao; Yanhu Lan; Jiabin Li
Journal:  Front Immunol       Date:  2020-07-31       Impact factor: 7.561

10.  The Host Microbiota Contributes to Early Protection Against Lung Colonization by Mycobacterium tuberculosis.

Authors:  Alexia Dumas; Dan Corral; André Colom; Florence Levillain; Antonio Peixoto; Denis Hudrisier; Yannick Poquet; Olivier Neyrolles
Journal:  Front Immunol       Date:  2018-11-14       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.